NOW YOUR PATIENTS CAN FOCUS ON LIFE. NOT ACNE.

Image

AKLIEF® (trifarotene) Cream, 0.005% HELPING THEM TO OPEN UP ABOUT ACNE IS THE FIRST STEP.

DOWNLOAD NOW
Image

AKLIEF Cream in action HOW TO USE.

DOWNLOAD NOW

They don't have to break the bank to save. PATIENT SAVINGS CARD DETAILS.

Your patients may pay as little as $0.*

Image
Image

Patients* can download a Patient Savings Card at GaldermaCC.com

This patient savings program* simply isn’t like other programs. The prescriptions you write can be easily filled by any participating pharmacy and your commercially-insured patients can pay less out-of-pocket. Easy enough?

*Galderma CareConnect is only available for commercially insured or uninsured patients. Patients who are enrolled in a government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card.

Restrictions apply. Please see Galderma CareConnect Patient Savings Card for details.

IMPORTANT SAFETY INFORMATION

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Please see full Important Safety Information below.

Scroll to ISI